Antitumor Effects of Radioiodinated Antisense Oligonuclide Mediated by VIP Receptor
Cancer Gene Therapy- United Kingdom
doi 10.1038/sj.cgt.7700787
Full Text
Abstract
Available in
Date
December 3, 2004
Authors
Publisher
Springer Science and Business Media LLC